Vineet Laboratories Limited (NSE:VINEETLAB)

India flag India · Delayed Price · Currency is INR
38.55
+2.11 (5.79%)
Apr 29, 2026, 3:29 PM IST
12.59%
Market Cap 699.88M
Revenue (ttm) 560.13M
Net Income (ttm) -101.39M
Shares Out 19.21M
EPS (ttm) -11.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 201,787
Average Volume 158,609
Open 37.36
Previous Close 36.44
Day's Range 36.51 - 39.00
52-Week Range 26.51 - 49.99
Beta -0.16
RSI 61.29
Earnings Date May 12, 2026

About Vineet Laboratories

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl th... [Read more]

Industry Chemicals
Sector Materials
Founded 2016
Employees 57
Stock Exchange National Stock Exchange of India
Ticker Symbol VINEETLAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.